Gut bacteria byproduct reduced brain damage in TBI mice
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Yan Qu at the Air Force Medical University in Shaanxi, China, led a study in which mice pre-treated with indole-3-propionic acid (IPA) — a byproduct of gut bacteria digesting tryptophan — showed less brain swelling, neuronal death, and tissue damage three days after a traumatic brain injury than control mice
- The same team measured IPA in blood samples from 106 people with traumatic brain injuries and found that higher levels were associated with less swelling around brain lesions and better neurological outcomes six months later
- IPA appeared to protect mitochondria inside astrocytes — brain support cells — by activating the aryl hydrocarbon receptor, preserving mitochondrial function while suppressing inflammation-linked immune responses
- Miguel Pappolla at the University of Texas Medical Branch in Galveston, whose team first reported IPA's neuroprotective properties in 1999, said the study significantly advances the field by identifying a detailed mechanism through which IPA preserves astrocytic mitochondrial regulation after injury
- Federico Rey at the University of Wisconsin–Madison stressed that this is prophylaxis, not therapy — "no one can pre-dose a car crash" — but said the approach could be explored in people at risk of repeated head impacts, such as contact-sport athletes or military personnel
- IPA is an inexpensive compound that can be taken orally, though Sonia Villapol at Houston Methodist Scholars noted doses may need tailoring because patients differ in age, sex, diet, medications, antibiotic use, and pre-existing microbiome composition
- The researchers said they plan further human studies on IPA and TBI outcomes, and that future studies should test IPA administration after an injury, not just before
Why it matters: The study points to a cheap, oral compound that could eventually be given preventatively to high-risk groups — military personnel and contact-sport athletes flagged by the researchers themselves — but the human data is correlational and the mouse model only tested pre-injury dosing. Qu's team acknowledged this gap and said future work will test IPA administered after injury.
Ask SkimNews
